纳美芬降低酒精依赖者的奖赏预期:一项实验性功能磁共振成像研究
18名受试者数据可分析,结果显示纳美芬显著降低纹状体感兴趣区的血氧水平依赖反应,且不改变脑灌注。
要点
- 纳美芬显著减弱酒精输注下金钱奖赏预期时的纹状体血氧水平依赖反应。
- 纳美芬未改变脑灌注,提示其效应不是通过整体血流变化介导。
- 结果与纳美芬作用于阿片受体调节中脑边缘多巴胺系统一致,为其疗效提供神经生物学基础。
核心结论
- 纳美芬减弱酒精输注下金钱奖赏预期时中脑边缘系统的血氧水平依赖反应,为其减少酒精消费的疗效提供神经生物学基础。
研究设计与样本
- 单剂量纳美芬(18 mg)与安慰剂比较,在静脉酒精输注(6% vol/vol,目标水平80 mg/dL)下用功能磁共振成像检测奖赏预期时纹状体感兴趣区血氧水平依赖信号变化。
主要发现
- 18名受试者数据可分析,在酒精输注存在时,纳美芬较安慰剂显著降低纹状体感兴趣区的血氧水平依赖反应。
- 纳美芬未改变脑灌注。
临床怎么用
- 纳美芬可能通过减弱奖赏预期相关的中脑边缘系统反应来减少酒精消费,支持其用于重饮酒酒精依赖者的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nalmefene is a µ and δ opioid receptor antagonist, κ opioid receptor partial agonist that has recently been approved in Europe for treating alcohol dependence. It offers a treatment approach for alcohol-dependent individuals with "high-risk drinking levels" to reduce their alcohol consumption. However, the neurobiological mechanism underpinning its effects on alcohol consumption remains to be determined. Using a randomized, double-blind, placebo-controlled, within-subject crossover design we aimed to determine the effect of a single dose of nalmefene on striatal blood oxygen level-dependent (BOLD) signal change during anticipation of monetary reward using the monetary incentive delay task following alcohol challenge. METHODS: Twenty-two currently heavy-drinking, non-treatment-seeking alcohol-dependent males were recruited. The effect of single dose nalmefene (18 mg) on changes in a priori defined striatal region of interest BOLD signal change during reward anticipation compared with placebo was investigated using functional magnetic resonance imaging. Both conditions were performed under intravenous alcohol administration (6% vol/vol infusion to achieve a target level of 80 mg/dL). RESULTS: Datasets from 18 participants were available and showed that in the presence of the alcohol infusion, nalmefene significantly reduced the BOLD response in the striatal region of interest compared with placebo. Nalmefene did not alter brain perfusion. CONCLUSIONS: Nalmefene blunts BOLD response in the mesolimbic system during anticipation of monetary reward and an alcohol infusion. This is consistent with nalmefene's actions on opioid receptors, which modulate the mesolimbic dopaminergic system, and provides a neurobiological basis for its efficacy.
引用
- Quelch DR, Mick I, McGonigle J, et al. Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study. Biol Psychiatry. 2017. PMID: 28216062. doi:10.1016/j.biopsych.2016.12.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。